Amyotrophic Lateral Sclerosis and Oral Health

  • Aakash Shah K.M. Shah Dental College and Hospital, Vadodara
  • Purvesh Shah K.M. Shah Dental College and Hospital, Vadodara, Gujarat, India
  • Santosh Kumar Goje K.M. Shah Dental College and Hospital, Vadodara, Gujarat, India
  • Romil Shah K.M. Shah Dental College and Hospital, Vadodara, Gujarat, India
  • Bhumi Modi K.M. Shah Dental College and Hospital, Vadodara, Gujarat, India

Abstract

Amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease is a progressive degenerative disorder that affects the nervous system, particularly the motor neurons. It may affect either spinal or bulbar neurons, which classify how symptoms present in the individual. Currently, the cause of ALS is unknown, although research indicates the possibility of genetic and environmental factors affecting its incidence. It is important for health care practitioners to understand amyotrophic lateral sclerosis to enable them to make modifications to patient care as needed.

Keywords: Respiratory, Amyotrophic Lateral Sclerosis, Periodontal, Oral hygiene, Pneumonia

Downloads

Download data is not yet available.

Author Biographies

Aakash Shah, K.M. Shah Dental College and Hospital, Vadodara

Post-graduate student (MDS), Department of Orthodontics and Dentofacial Orthopedics, K.M. Shah Dental College and Hospital, Vadodara, Gujarat, India

Purvesh Shah, K.M. Shah Dental College and Hospital, Vadodara, Gujarat, India

Reader, Department of Orthodontics and Dentofacial Orthopedics, K.M. Shah Dental College and Hospital, Vadodara, Gujarat, India

Santosh Kumar Goje, K.M. Shah Dental College and Hospital, Vadodara, Gujarat, India

Professor and Head, Department of Orthodontics and Dentofacial Orthopedics, K.M. Shah Dental College and Hospital, Vadodara, Gujarat, India

Romil Shah, K.M. Shah Dental College and Hospital, Vadodara, Gujarat, India

Reader, Department of Orthodontics and Dentofacial Orthopedics

Bhumi Modi, K.M. Shah Dental College and Hospital, Vadodara, Gujarat, India

Reader, Department of Orthodontics and Dentofacial Orthopedics

References

[1] Spataro, M. L. Re, T. Piccoli, F. Piccoli, and V. L. Bella, “Causes and place of death in Italian patients with amyotrophic lateral sclerosis,” Acta Neurologica Scandinavica, vol. 122, no. 3, pp. 217–223, 2010. Article
[2]  F. A. Scannapieco, R. B. Bush, and S. Paju, “Associations Between Periodontal Disease and Risk for Nosocomial Bacterial Pneumonia and Chronic Obstructive Pulmonary Disease. A Systematic Review,” Annals of Periodontology, vol. 8, no. 1, pp. 54–69, 2003. Article
[3]            J. M. Cedarbaum and N. Stambler, “Disease status and use of ventilatory support by ALS patients,” Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, vol. 2, no. 1, pp. 19–22, 2001. Article
[4]            L. P. Rowland, “How Amyotrophic Lateral Sclerosis Got Its Name,” Archives of Neurology, vol. 58, no. 3, Jan. 2001. Article
[5] D. Walling, “Amyotrophic lateral sclerosis: Lou Gehrig's disease,” American family physician, vol. 59, no. 6, pp. 1489-1496, 1999. View
[6]            R. W. Orrell, J. J. Habgood, I. Gardiner, A. W. King, F. A. Bowe, R. A. Hallewell, S. L. Marklund, J. Greenwood, R. Lane, and J. Debelleroche, “Clinical and functional investigation of 10 missense mutations and a novel frameshift insertion mutation of the gene for copper-zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis,” Neurology, vol. 48, no. 3, pp. 746–751, Jan. 1997. Article
[7]            M. E. Cudkowicz, D. Mckenna-Yasek, P. E. Sapp, W. Chin, B. Geller, D. L. Hayden, D. A. Schoenfeld, B. A. Hosler, H. R. Horvitz, and R. H. Brown, “Epidemiology of mutations in superoxide dismutase in amyotrophic lateal sclerosis,” Annals of Neurology, vol. 41, no. 2, pp. 210–221, 1997. Article
[8]            A. Cifra, F. Nani, and A. Nistri, “Riluzole is a potent drug to protect neonatal rat hypoglossal motoneurons in vitro from excitotoxicity due to glutamate uptake block,” European Journal of Neuroscience, vol. 33, no. 5, pp. 899–913, 2011. Article
[9]            K. M. Kurian, R. B. Forbes, S. Colville, and R. J. Swingler, “Cause of death and clinical grading criteria in a cohort of amyotrophic lateral sclerosis cases undergoing autopsy from the Scottish Motor Neurone Disease Register,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 80, no. 1, pp. 84–87, 2008. Article
[10]         P. Corcia, P. F. Pradat, F. Salachas, G. Bruneteau, N. L. Forestier, D. Seilhean, J. J. Hauw, and V. Meininger, “Causes of death in a post‐mortem series of ALS patients,” Amyotrophic Lateral Sclerosis, vol. 9, no. 1, pp. 59–62, 2008. Article
[11] Mochizuki, A. Kawata, T. Hashimoto, H. Akiyama, H. Kawakami, T. Komori, K. Oyanagi, T. Mizutani, and S. Matsubara, “An autopsy case of familial amyotrophic lateral sclerosis withFUSR521G mutation,” Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, vol. 15, no. 3-4, pp. 305–308, 2014. Article
[12]         M. S. Terpenning, G. W. Taylor, D. E. Lopatin, C. K. Kerr, B. L. Dominguez, and W. J. Loesche, “Aspiration Pneumonia: Dental and Oral Risk Factors in an Older Veteran Population,” Journal of the American Geriatrics Society, vol. 49, no. 5, pp. 557–563, 2001. Article
[13]         S. E. Langmore, M. S. Terpenning, A. Schork, Y. Chen, J. T. Murray, D. Lopatin, and W. J. Loesche, “Predictors of Aspiration Pneumonia: How Important Is Dysphagia?,” Dysphagia, vol. 13, no. 2, pp. 69–81, 1998. Article
[14]         P. Mojon, E. Budtz-Jorgensen, J.-P. Michel, and H. Limeback, “Oral health and history of respiratory tract infection in frail institutionalised elders,” Gerodontology, vol. 14, no. 1, pp. 9–16, 1997. Article
[15]         F. A. Scannapieco, R. B. Bush, and S. Paju, “Associations Between Periodontal Disease and Risk for Atherosclerosis, Cardiovascular Disease, and Stroke. A Systematic Review,” Annals of Periodontology, vol. 8, no. 1, pp. 38–53, 2003. Article
[16]         V. Deo, M. Bhongade, S. Ansari, and R. Chavan, “Periodontitis as a potential risk factor for chronic obstructive pulmonary disease: A retrospective study,” Indian Journal of Dental Research, vol. 20, no. 4, p. 466, 2009. Article
[17]         A. A. El-Solh, M. S. Niederman, and P. Drinka, “Nursing home-acquired pneumonia: a review of risk factors and therapeutic approaches,” Current Medical Research and Opinion, vol. 26, no. 12, pp. 2707–2714, 2010. Article
[18]         A. Radunovic, D. Annane, K. Jewitt, and N. Mustfa, “Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease,” Cochrane Database of Systematic Reviews, Jul. 2009. Article
[19]         M. S. Sherman and H. L. Paz, “Review of Respiratory Care of the Patient with Amyotrophic Lateral Sclerosis,” Respiration, vol. 61, no. 2, pp. 61–67, 2009. Article
[20]         N. Lechtzin, J. Rothstein, L. Clawson, G. B. Diette, and C. M. Wiener, “Amyotrophic lateral sclerosis: evaluation and treatment of respiratory impairment,” Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, vol. 3, no. 1, pp. 5–13, 2002. Article
[21]         A. H. Moss, E. A. Oppenheimer, P. Casey, P. A. Cazzolli, R. P. Roos, C. B. Stocking, and M. Siegler, “Patients With Amyotrophic Lateral Sclerosis Receiving Long-term Mechanical Ventilation,” Chest, vol. 110, no. 1, pp. 249–255, 1996. Article
[22]         L. Ng and F. Khan, “Multidisciplinary care for adults with amyotrophic lateral sclerosis or motor neuron disease,” Cochrane Database of Systematic Reviews, Jul. 2009.  Article
[23]         R. L. Vender, D. Mauger, S. Walsh, S. Alam, and Z. Simmons, “Respiratory systems abnormalities and clinical milestones for patients with amyotrophic lateral sclerosis with emphasis upon survival,” Amyotrophic Lateral Sclerosis, vol. 8, no. 1, pp. 36–41, 2007. Article
[24]         N. Lechtzin, C. M. Wiener, L. Clawson, M. C. Davidson, F. Anderson, N. Gowda, and G. B. Diette, “Use of noninvasive ventilation in patients with amyotrophic lateral sclerosis,” Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, vol. 5, no. 1, pp. 9–15, 2004. Article
[25]         M. H. Kollef and D. P. Schuster, “Ventilator-associated pneumonia: clinical considerations.,” American Journal of Roentgenology, vol. 163, no. 5, pp. 1031–1035, 1994. Article
[26]         S. Randall and T. Alfred, “Dental management of long-term amyotrophic lateral sclerosis: Case report,” Special Care in Dentistry, vol. 13, no. 6, pp. 241–244, 1993. Article
[27]         A. Berry, P. Davidson, J. Masters, K. Rolls, and R. Ollerton, “Effects of three approaches to standardized oral hygiene to reduce bacterial colonization and ventilator associated pneumonia in mechanically ventilated patients: A randomised control trial,” International Journal of Nursing Studies, vol. 48, no. 6, pp. 681–688, 2011. Article
[28]         A. Azarpazhooh and J. L. Leake, “Systematic Review of the Association Between Respiratory Diseases and Oral Health,” Journal of Periodontology, vol. 77, no. 9, pp. 1465–1482, 2006. Article
[29]         H. Tantipong, C. Morkchareonpong, S. Jaiyindee, and V. Thamlikitkul, “Randomized Controlled Trial and Meta-analysis of Oral Decontamination with 2% Chlorhexidine Solution for the Prevention of Ventilator-Associated Pneumonia,” Infection Control & Hospital Epidemiology, vol. 29, no. 02, pp. 131–136, 2008. Article
[30]         R. Garcia, L. Jendresky, L. Colbert, A. Bailey, M. Zaman, and M. Majumder, “Reducing Ventilator-Associated Pneumonia Through Advanced Oral-Dental Care: A 48-Month Study,” American Journal of Critical Care, vol. 18, no. 6, pp. 523–532, 2009. Article
[31]         E. Y. Chan, A. Ruest, M. O. Meade, and D. J. Cook, “Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysis,” Bmj, vol. 334, no. 7599, pp. 889–889, 2007. Article
[32]         F. Fourrier, E. Cau-Pottier, H. Boutigny, M. Roussel-Delvallez, M. Jourdain, and C. Chopin, “Effects of dental plaque antiseptic decontamination on bacterial colonization and nosocomial infections in critically ill patients,” Intensive Care Medicine, vol. 26, no. 9, pp. 1239–1247, 2000. Article
[33]         C. Neudert, D. Oliver, M. Wasner, and G. D. Borasio, “The course of the terminal phase in patients with amyotrophic lateral sclerosis,” Journal of Neurology, vol. 248, no. 7, pp. 612–616, Jan. 2001. Article
[34]         N. Lechtzin, C. M. Wiener, L. Clawson, V. Chaudhry, and G. B. Diette, “Hospitalization in amyotrophic lateral sclerosis: Causes, costs, and outcomes,” Neurology, vol. 56, no. 6, pp. 753–757, 2001. Article
[35]         L. Ganzini, W. S. Johnston, and M. J. Silveira, “The final month of life in patients with ALS,” Neurology, vol. 59, no. 3, pp. 428–431, 2002. Article
[36]         J. Gil, B. Funalot, A. Verschueren, V. Danel-Brunaud, W. Camu, N. Vandenberghe, C. Desnuelle, N. Guy, J. P. Camdessanche, P. Cintas, L. Carluer, S. Pittion, G. Nicolas, P. Corcia, M.-C. Fleury, C. Maugras, G. Besson, G. L. Masson, and P. Couratier, “Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study,” European Journal of Neurology, vol. 15, no. 11, pp. 1245–1251, 2008. Article

Published
2017-08-18
Section
Graduate Reviews
How to Cite
[1]
A. Shah, P. Shah, S. K. Goje, R. Shah, and B. Modi, “Amyotrophic Lateral Sclerosis and Oral Health”, Advanced Journal of Graduate Research, vol. 3, no. 1, pp. 13-19, Aug. 2017.